Furthermore, we show that both IL-21 and IFN-γ are critical cytokines in autoimmune attack during ICI-T1DM and that inhibition of these cytokine pathways by JAKi therapy can prevent ICI-T1DM. The gene discussed is IL21; the disease is type 1 diabetes mellitus.